Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Continuous maintenance (Maint) capecitabine (Cape) dosing for colorectal (CRC) and pancreatic cancers (PC): A single-institution, retrospective, real-world study.
Authors
Reetu Mukherji
MedStar Georgetown University Hospital, Washington, DC;
Reetu Mukherji , Chao Yin , Benjamin Adam Weinberg , Ali Alqahtani , Rumaisa Hameed , Anna Barcellos , Maegan Connole , Chelsea Perelgut , Josephine Fortuin , John Marshall
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 789)
DOI
10.1200/JCO.2023.41.4_suppl.789
Abstract #
789
Poster Bd #
M4
Abstract Disclosures